FATAL EXERTIONAL HEAT STROKE IN A PATIEN T RECEIVING ZUCLOPENTHIXOL, QUETIAPINE AND BENZTROPINE
Main Article Content
Keywords
Heat, heat stroke, fatal, zuclopenthixol, quetiapine, benztropine, antipsychotic
Abstract
Objective
To report a case of fatal exertional heat stroke associated with the use of zuclopenthixol, quetiapine and benztropine.
Case Summary
A 36-year-old male with a history of schizophrenia and bipolar disease was working as a roofer during the third day of a heat wave. His medications included zuclopenthixol, quetiapine, benztropine, carbamazepine and levothyroxine. He developed loss of consciousness late in the day and presented to hospital with a Glasgow Coma Scale 3 and a rectal temperature of 42.20C. He progressed to severe multiple organ dysfunction and asystole, and expired the following morning. Neuroleptic and anticholinergic agents have long been associated with heat alteration, but there are few reports involving the newer antipsychotic agents. Physicians and pharmacists should ensure that appropriate counseling is given to patients receiving these medications regarding early recognition of signs and symptoms and prompt treatment of heat related illness and heat stroke.
References
2. Knochel JP. Dog days and siriasis. How to kill a football player. J Am Med Assoc 1975;233:513-515.
3. Martinez M, Devenport L, Saussy J, Martinez J. Drug-associated heat stroke. South Med J 2002;95:799-802.
4. Prevention and treatment of heat injury. Med Lett Drugs Ther 2003;45:58-60.
5. Knochel JP, Reed G. Disorders of heat regulation. In: Kleeman CR, Maxwell MH, Narin RG (ed). Clinical disorder of fluids and electrolyte metabolism. New York, McGraw- Hill, 1987.
6. Gisolfi CV, Wenger CB. Temperature regulation during exercise: old concepts, new ideas. Exerc Sports Sci Rev 1984;12:339.
7. Hubbard RW, et al. Heat-related illness. In:Aurebach PS (ed). Wilderness Medicine 1985. New York, Mosby.
8. Lugo-Amador NM, Rothenhaus T, Moyer P. Heat- Related illness. Emerg Med Clin North Am 2004;22:315-327.
9. Yeo TP. Heat stroke: a comprehensive review. AACN Clin Issues 2004;15:280-293.
10. Hart GR, Anderson JF, Crumpler CP, Shulkin A, Reed G, Knochel JP. Epidemic classical heat stroke: Clinical characteristics and course of 28 patients. Medicine 1982;61:189.
11. Lomax P, Schonbaum E. The effects of drugs on thermoregulation during exposure to hot environments. Prog Brain Res 1998;115:193-204.
12. Clark WG, Lipton JM. Drug related heat stroke. Pharmacol Ther 1984;26:345-388.
13. Johnson DH, Cunha BA. Drug fever. Inf Dis Clin N Amer 1996;10(1):85-91.
14. Tabor PA. Drug–induced fever. Drug Intell Clin Pharm 1996;20(6):413-420.
15. Woodhouse K. Disorder of temperature regulation. In: Davies DM, Ferner RE, deGlanville H. Davies textbook of adverse drug reactions. New York: Chapman & Hall Medical 1998;857-864.
16. Hensel H. Neural process in the thermoregulation. Physio Rev 1973;53:948-1007.
17. Kollias J, Bullard RW. The influence of chlorpromazine on physical and chemical mechanisms of temperature regulation in the rat. J Pharmacol Exp Ther 1984;145:373 -381.
18. Berti T, Cima L. Influenza della temperatura sullazione farmacologica della chlorpromazine.Arch Ita Sci Farmocol 1954;4:273 -274.
19. Ayd FJ. Fatal hyperpyrexia during chlorpromazine therapy. J Clin Exp Psychopathol Q Rev Psychiatry Neurol 1956;17:189-192.
20. Kwok JS, Chan TYK. Recurrent heat-related illness during antipsychotic treatment. Ann Pharmcother 2005;39:1940 -1942.
21. Bark N. Deaths of psychiatric patients during heat waves. Psychiatri Serv 1998;49:1088-1090.
22. Lin M, Wang HC, Chandra A. The effects on thermoregulation of intracerebroventricular injection of acetylcholine, pilocarpine, physostigmine, atropine and hemicholinium in the rat. Neuropharmacology 1980;19:561 -565.
23. Kerwin RW, Osborne S, Sainz-Fuertes R. Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management. J of Pharmacol 2004;8(1):121 -123.
24. Steward CR, Venfrow MI, Riley TL. Double quotidian caused by carbamazepine. N Engl J Med 1980;302:1262.
25. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reaction. Clin Pharmacol Ther 1981;30:239-45.